(Q44291068)

1 December 2017

title

Drug interactions in palliative care--it's more than cytochrome P450. (English)

1 reference

1 December 2017

Jan Gaertner

1

1 reference

1 December 2017

Klaus Ruberg

2

1 reference

1 December 2017

Grit Schlesiger

3

1 reference

1 December 2017

Sebastian Frechen

4

1 reference

1 December 2017

Raymond Voltz

5

1 reference

1 December 2017

publication date

7 July 2011

1 reference

1 December 2017

1 reference

1 December 2017

volume

26

1 reference

1 December 2017

issue

6

1 reference

1 December 2017

page(s)

813-825

1 reference

Drug interactions in oncology: how common are they?

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Drug-drug interactions among elderly patients hospitalized for drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Antiepileptic drugs in the treatment of neuropathic pain: drug-to-drug interaction in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Physicians' decisions to override computerized drug alerts in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Pharmacokinetic drug interactions in palliative care: focus on opioids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug-drug interaction prediction methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Actual and potential drug interactions associated with methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Implications of opioid analgesia for medically complicated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Drug interactions with patient-controlled analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Case report: delirium due to a diltiazem-fentanyl CYP3A4 drug interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Dihydrocodeine as an opioid analgesic for the treatment of moderate to severe chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

The visceral and somatic antinociceptive effects of dihydrocodeine and its metabolite, dihydromorphine. A cross-over study with extensive and quinidine-induced poor metabolizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Risk factors for the development of gastric mucosal lesions in rheumatoid arthritis patients receiving long-term nonsteroidal anti-inflammatory drug therapy and the efficacy of famotidine obtained from the FORCE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Unerwünschte Wirkungen und Wechselwirkungen in der Analgetikatherapie

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Update on the role of non-opioids for postoperative pain treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: comparison with acetaminophen and diclofenac

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Update on guidelines for the treatment of chronic musculoskeletal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Management of refractory breathlessness in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Comparative tolerability of newer agents for insomnia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

A sleep laboratory evaluation of the long-term efficacy of zopiclone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Antidepressant drug-drug interaction profile update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

NSAID-induced gastrointestinal and cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

A comprehensive review of the loop diuretics: should furosemide be first line?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Provision of palliative care for chronic heart failure inpatients: how much do we need?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Death rattle: its impact on staff and volunteers in palliative care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Clinically relevant drug interactions with antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

Caring for the treatment-experienced breast cancer patient: the pharmacist's role

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269216311412231

21 January 2018

Identifiers

DOI

10.1177/0269216311412231

1 reference

1 December 2017

1 reference